Infektolo\u0123ija ir pla\u0161a joma, kur katrs var ko sev atrast, \u0161\u012bs slim\u012bbas vienm\u0113r b\u016bs aktu\u0101las, un te diezgan \u0101tri var redz\u0113t \u0101rst\u0113\u0161anas rezult\u0101tu. Tie bija iemesli, kas \u0161ai jomai piesaist\u012bja Li\u0101nu Lindu Skrau\u010du, jauno \u0101rsti infektolo\u0123i, kura savas gaitas rezident\u016br\u0101 uzs\u0101ka kovida pand\u0113mijas intens\u012bv\u0101kaj\u0101 laik\u0101 un kura p\u0113rn decembr\u012b sa\u0146\u0113ma Dr. Paula Aldi\u0146a piemi\u0146as stipendiju.<\/p>\n
To vi\u0146a ieguva par noz\u012bm\u012bgo p\u0113tniecisko darbu zeltain\u0101 stafilokoka bakteri\u0113miju izn\u0101kumos. \u0160\u012b bakt\u0113rija \u012bpa\u0161i apdraud pacientus ar nom\u0101ktu imunit\u0101ti. K\u0101 Skrau\u010da non\u0101ca l\u012bdz \u0101rsta profesijai, ko p\u0113t\u012bja un k\u0101di ir infektologu n\u0101kotnes izaicin\u0101jumi, pla\u0161\u0101k Latvijas Radio\u00a0intervij\u0101.<\/p>\n
Infektolo\u0123ij\u0101 m\u0113s diezgan \u0101tri redzam \u0101rst\u0113\u0161anas rezult\u0101tu. Saruna ar Dr. Paula Aldi\u0146a piemi\u0146as stipendijas sa\u0146\u0113m\u0113ju<\/p>\n
Laura Dz\u0113rve: S\u0101ksim ar to, kur\u0101 br\u012bd\u012b vai kur\u0101 laik\u0101 j\u016bs saprat\u0101t, ka j\u016bs v\u0113laties b\u016bt tie\u0161i \u0101rste?<\/p>\n
Li\u0101na Linda Skrau\u010da: Man tas s\u0101kums dro\u0161i vien ir stipri saist\u0101ms ar\u012b ar to, ka mana mamma ir \u0123imenes \u0101rsts un paral\u0113li str\u0101d\u0101ja ar\u012b neatliekam\u0101s medic\u012bnas pal\u012bdz\u012bbas centr\u0101. L\u012bdz ar to t\u0101 vide bija paz\u012bstama kaut k\u0101d\u0101 m\u0113r\u0101. Man lik\u0101s interesanti tie st\u0101sti, un nozare un dro\u0161i vien, ka tas bija t\u0101ds b\u016btisk\u0101kais faktors.<\/p>\n
Vai neatbaid\u012bja garais darba laiks?<\/p>\n
Es sapratu, ka tas nav viegli. Mammai, k\u0101 \u0123imenes \u0101rstam, tas darbs bija ambulator\u0101 praks\u0113. Man lik\u0101s \u2013 ja es str\u0101d\u0101\u0161u slimn\u012bc\u0101, tas var\u0113tu b\u016bt viegl\u0101k varb\u016bt.<\/p>\n
Decembr\u012b j\u016bs sa\u0146\u0113m\u0101t Dr. Paula Aldi\u0146a piemi\u0146as stipendiju infektolo\u0123ij\u0101. Pa\u0161u Aldi\u0146u es diem\u017e\u0113l neesmu satikusi, vi\u0146\u0161 p\u0101ragri nomira p\u0113c saslim\u0161anas ar kovidu, ta\u010du savulaik es rakst\u012bja par vi\u0146u port\u0101l\u0101 “Delfi” un uzzin\u0101ju\u00a0no vi\u0146a meitas Madaras par vi\u0146a motiv\u0101ciju piev\u0113rsties infektolo\u0123ijai. Ka vi\u0146\u0161 teicis, ka studiju laik\u0101 vi\u0146am bija daudz, kas licies interesants. \u0136irur\u0123ija \u2013 \u013coti interesanta, bet tad vi\u0146\u0161 paskat\u012bjies uz sav\u0101m rok\u0101m un sapratis, ka neb\u016bs. Ka pirksti vi\u0146am nav tik veikli. Traumatolo\u0123ija \u013coti pat\u012bk, bet ar\u012b tur ir, k\u0101 galdniec\u012bb\u0101, filigr\u0101ni j\u0101sl\u012bp\u0113 \u2013 t\u0101p\u0113c ar\u012b neb\u016bs. Ta\u010du infektolo\u0123ija, k\u0101 vi\u0146\u0161 atzinis, t\u0101 ir pla\u0161a. Tur ir gan s\u012bkas nianses, gan lielas lietas, un katrs var atrast kaut ko savu. K\u0101 jums ir bijis ar \u0161o izv\u0113li? T\u0101 bija sare\u017e\u0123\u012bta, kas to noteica?<\/p>\n
Attiec\u012bb\u0101 uz infekcijas slim\u012bb\u0101m, \u013coti b\u016btiski manai izv\u0113lei bija tas, ka ir pieejama \u0101rst\u0113\u0161ana, un ka t\u0101 dinamika ir redzama. Piem\u0113ram, septiskiem pacientiem, sa\u0146emot antibiotikas laik\u0101, – turkl\u0101t ne tikai sepses, bet jebkuras infekcijas pacientiem, \u012bpa\u0161i ak\u016btu infekciju gad\u012bjum\u0101, – m\u0113s diezgan \u0101tri redzam rezult\u0101tu. Gan no pacienta puses, gan ar\u012b laboratoriski. Tas man patika, tas ar\u012b bija t\u0101ds motivators.<\/p>\n
Ar\u012b tas izv\u0113les spektrs, kur darboties, ir \u013coti pla\u0161s. Infektolo\u0123ij\u0101 tas var b\u016bt ambulators darbs, t\u0101pat ar\u012b hronisku infekciju pacienti, piem\u0113ram, hepat\u012btu, HIV pacienti, kuriem savuk\u0101rt ir t\u0101 iesp\u0113ja sekot l\u012bdzi ilg\u0101k\u0101 laika posm\u0101. Savuk\u0101rt slimn\u012bc\u0101 ir t\u0101das vair\u0101k ak\u016btas epizodes.<\/p>\n
Vai j\u016bs t\u0101du savu lietu esat atradusi infektolo\u0123ij\u0101?<\/p>\n
Jebkur\u0101 gad\u012bjum\u0101 esmu sava ce\u013ca s\u0101kum\u0101. Man pat\u012bk darbs slimn\u012bc\u0101. Mums ir infekcijas uzraudz\u012bbas dienests, kur str\u0101d\u0101 \u0101rsti, infektologi-konsultanti.<\/p>\n
T\u0101 ikdienas dz\u012bve man vair\u0101k saist\u0101ma ar to, ka t\u0101s ir konsult\u0101cijas. Infektologu pieaicina, kad komplic\u0113t\u0101kas situ\u0101cijas notiek, kad ir vajadz\u012bgs (speci\u0101lista) viedoklis ar\u012b, taj\u0101 skait\u0101, antimikrobi\u0101l\u0101s rezistences jaut\u0101jumos par piem\u0113rotu terapiju. \u0160ie antimikrobi\u0101l\u0101s rezistences jaut\u0101jumi par atbild\u012bgu antibiotiku lieto\u0161anu. Diena paiet konsult\u0101cij\u0101s, kas ir gan telefoniskas ar \u0101rst\u0113jo\u0161o \u0101rstu, gan ar\u012b kl\u0101tienes, ejot skat\u012bties pacientu uz vietas k\u0101 \u0101rstam-konsultantam.<\/p>\n
Dr.Paula Aldi\u0146a stipendiju j\u016bs sa\u0146\u0113m\u0101t par p\u0113t\u012bjumu, kas skar zeltaino stafilokoku. K\u0101 es palas\u012bju, t\u0101 ir da\u013ca no cilv\u0113ka mikrobioma. Bie\u017ei sastopams ar\u012b, piem\u0113ram, uz \u0101das. Un, lai gan tipiski starp zeltaino stafilokoku un cilv\u0113ku valdot attiec\u012bbas, kuras vienam organismam ir labv\u0113l\u012bgas, bet otram neitr\u0101las. tom\u0113r da\u013cai cilv\u0113ku, \u012bpa\u0161i ar pazemin\u0101tu imunit\u0101ti, tas var izrais\u012bt ne tikai vesel\u012bbas probl\u0113mas, piem\u0113ram, furunku\u013cus, bet var b\u016bt pat let\u0101ls. K\u0101d\u0113\u013c j\u016bs tie\u0161i to p\u0113t\u012bj\u0101t?<\/p>\n
P\u0113tniec\u012bbas aspekt\u0101 man lik\u0101s svar\u012bgi, ka es gribu fokus\u0113ties uz kaut ko, kas ir bie\u017ei sastopams. Es ar\u012b redz\u0113ju to, cik agres\u012bvi norit \u0161\u012b (slim\u012bba). M\u0113s bie\u017e\u0101k to saucam par Staphylococcus aureus, t\u0101p\u0113c ar\u012b tas “aureus”- zelts tulkojum\u0101. Turkl\u0101t es ar\u012b las\u012bju literat\u016br\u0101 un ar\u012b redz\u0113ju \u0161os augstos mirst\u012bbas r\u0101d\u012bt\u0101jus. Biju ar\u012b las\u012bjusi p\u0113t\u012bjumus, kas v\u0113rsti ar\u012b uz to, ko sauc par t\u0101diem kvalit\u0101tes krit\u0113rijiem. T\u0101s ir diagnostikas un \u0101rst\u0113\u0161anas vadl\u012bnijas, kas pier\u0101d\u012bju\u0161as sevi k\u0101 mirst\u012bbu mazino\u0161as.<\/p>\n
\u0145emot v\u0113r\u0101, ka Staphylococcus aureus ir viens no domin\u0113jo\u0161ajiem bakter\u0113miju ierosin\u0101t\u0101jiem, man lik\u0101s \u013coti interesanti un ar\u012b vajadz\u012bgi zin\u0101t, k\u0101 tad mums veicas ar diagnostiku un, vai mirst\u012bbas r\u0101d\u012bt\u0101ji at\u0161\u0137iras no tiem, kas ir zin\u0101mi literat\u016br\u0101, un k\u0101di b\u016btu tie so\u013ci, kurus mums vajadz\u0113tu uzlabot, lai nestu lab\u0101ku rezult\u0101tu pacientiem.<\/p>\n
J\u016bsu p\u0113t\u012bjuma prezent\u0101cijas secin\u0101jumos las\u012bju, ka mirst\u012bba ir augst\u0101ka nek\u0101 l\u012bdz \u0161im public\u0113ts. K\u0101d\u0113\u013c t\u0101?<\/p>\n
Es analiz\u0113ju kvalit\u0101tes krit\u0113rijus. piem\u0113ram, ir \u0101rk\u0101rt\u012bgi b\u016btiski pie Staphylococcus aureus bakter\u0113mijas izsl\u0113gt v\u0101rstu\u013cu infekciju jeb endokard\u012btu, kas ir dz\u012bv\u012bbu apdraudo\u0161s st\u0101voklis, \u012bpa\u0161i \u0161aj\u0101 pacientu grup\u0101. Tas bija ar\u012b t\u0101ds viens no kvalit\u0101tes krit\u0113riju r\u0101d\u012bt\u0101jiem, ar kuriem gan kopum\u0101 veic\u0101s labi, ta\u010du ir v\u0113l \u013coti b\u016btiskas nianses, kas p\u0113t\u012bjuma gait\u0101 atkl\u0101j\u0101s. K\u0101, piem\u0113ram, laiks l\u012bdz laic\u012bgai antibiotiku uzs\u0101k\u0161anai, kas septiskiem pacientiem un ar\u012b bakter\u0113mijas pacientiem ir \u0101rk\u0101rt\u012bgi b\u016btisks, jo uzlabo izdz\u012bvot\u012bbu.<\/p>\n
\u0100rk\u0101rt\u012bgi svar\u012bgi pirms tam pa\u0146emtie asins uzs\u0113jumi, lai m\u0113s visp\u0101r var\u0113tu identific\u0113t \u0161o ierosin\u0101t\u0101ju un l\u012bdz ar to ar\u012b piel\u0101got efekt\u012bvas antibiotikas. Atkl\u0101j\u0101s lietas, kas ir b\u016btiskas ne tikai \u0161o kvalit\u0101tes krit\u0113riju r\u0101d\u012bt\u0101ju sakar\u0101.<\/p>\n
Ta\u010du, ja ir kas nov\u0113lots, ko tur var dr\u012bz\u0101k vainot \u2013 pacientu, kas p\u0101r\u0101k v\u0113lu ir v\u0113rsies pie speci\u0101lista ar sav\u0101m vesel\u012bbas probl\u0113m\u0101m, vai \u0101rsti, kas nav nov\u0113rt\u0113ju\u0161i situ\u0101ciju?<\/p>\n
Dro\u0161i vien, ka tas nav ne melns, ne balts, un t\u0101 paties\u012bba ir kaut kur vidusce\u013c\u0161. \u0160iem pacientiem, it \u012bpa\u0161i, ja vi\u0146iem ir, piem\u0113ram, k\u0101das prot\u0113\u017eu infekcijas, ko bie\u017ei vien izraisa Staphylococcus aureus, bie\u017ei vien ar\u012b tie simptomi var\u0113tu neb\u016btu tik dramatiski s\u0101kum\u0101. Kaut gan \u0161iem pacientiem ir rakstur\u012bga augsta temperat\u016bra 39-40 gr\u0101di. st\u0101vok\u013ca, gan ar\u012b no apr\u016bpes, kas ir medi\u0137u lauci\u0146\u0161.<\/p>\n
Ta\u010du j\u0101saka, ka, protams, ir ko uzlabot. T\u0101p\u0113c man\u0101 p\u0113t\u012bjum\u0101 k\u0101 t\u0101ds gala variants ir manis izstr\u0101d\u0101tais algoritms, kas ir pieejams visiem \u0101rstiem Latvij\u0101 ar\u012b caur aplik\u0101ciju vai caur AMR centra (Antimikrobi\u0101l\u0101s rezistences kompetences centrs \u2013 red.) m\u0101jaslapu, kur ir \u0161is diagnostiskais algoritms, kas ir adapt\u0113ts no citiem iepriek\u0161\u0113jiem.<\/p>\n
\nMan bija b\u016btiski, lai tas b\u016btu t\u0101ds maksim\u0101li kodol\u012bgs un vado\u0161s \u2013 t\u0101ds, kas pal\u012bdz\u0113tu pacientus pareizi, p\u0113c iesp\u0113jas lab\u0101kaj\u0101m rekomend\u0101cij\u0101m diagnostic\u0113t un \u0101rst\u0113t.<\/p>\n<\/blockquote>\n
Vai var b\u016bt, ka pacients slimn\u012bc\u0101 \u0101rst\u0113jas ar k\u0101du citu slim\u012bbu, bet tur, slimn\u012bc\u0101, no\u0137er ar\u012b \u0161o bakt\u0113riju?<\/p>\n
T\u0101 k\u0101 Staphylococcus aureus, k\u0101 j\u016bs ar\u012b pareizi nor\u0101d\u012bj\u0101t, dz\u012bvo \u013coti daudziem uz \u0101das, tad, j\u0101, jebkuri sve\u0161\u0137erme\u0146i, piem\u0113ram, intravenozie katetri, traheostomas, ir k\u0101 t\u0101di va\u013c\u0113ji v\u0101rti, kas izjauc dabisko \u0101das barjeru. L\u012bdz ar to tie ir v\u0101rti, lai bakt\u0113rijas ar\u012b var\u0113tu nok\u013c\u016bt asinsrit\u0113 un izrais\u012bt to, ko jau m\u0113s saucam par metast\u0101tiskiem infekcijas per\u0113k\u013ciem. Piem\u0113ram, tie ir endokard\u012bti, muguras skrieme\u013cu iekaisumi. T\u0101 ir viena no b\u016btisk\u0101m liet\u0101m ar\u012b slimn\u012bc\u0101, kas ir atkar\u012bga gan no pacienta visp\u0101r\u0113j\u0101 vesel\u012bbas<\/p>\n
J\u0101, t\u0101 diem\u017e\u0113l ir, ka Staphylococcus aureus bakter\u0113mijas ir diezgan bie\u017ea lieta ar\u012b slimn\u012bcas etap\u0101, un tas ar\u012b bija t\u0101ds b\u016btisks faktors, ko es grib\u0113ju \u0161aj\u0101 p\u0113t\u012bjum\u0101 ar\u012b analiz\u0113t – k\u0101da tad ir t\u0101 attiec\u012bba starp sadz\u012bv\u0113 ieg\u016bto un slimn\u012bc\u0101 ieg\u016bto.<\/p>\n
Ta\u010du sadz\u012bv\u0113 zeltainais stafilokoks vair\u0101k attiecas t\u0101 k\u0101 uz pacientiem, kuriem ir nom\u0101kta imunit\u0101ti? Tie var b\u016bt, piem\u0113ram, im\u016bnsupres\u0113tie pacienti p\u0113c org\u0101nu transplant\u0101cijas vai ar\u012b v\u0113l citi?<\/p>\n
P\u0101rsvar\u0101 tie ir pacienti, kuriem ir im\u016bnsupresija. K\u0101 viens t\u0101ds \u013coti b\u016btisks faktors jebkurai bakteri\u0101lai infekcijai un ar\u012b vir\u0101l\u0101m s\u0113\u0146u (infekcij\u0101m) ir cukura diab\u0113ts, it \u012bpa\u0161i, ja tas ir ne \u012bpa\u0161i labi kontrol\u0113ts.<\/p>\n
Rezident\u016bras laik\u0101 j\u016bs str\u0101d\u0101j\u0101t Stradi\u0146a slimn\u012bc\u0101, un s\u0101kums sakrita tie\u0161i ar pa\u0161u kovida intensit\u0101tes s\u0101kuma laiku 2020. gada ruden\u012b. L\u012bdz ar to san\u0101k – tas, ko j\u016bs m\u0101c\u012bj\u0101ties augstskol\u0101 par pand\u0113mij\u0101m, piem\u0113ram, sp\u0101\u0146u gripu, piepe\u0161i notika atkal Latvij\u0101?<\/p>\n
J\u0101. Ar infekcijas slim\u012bb\u0101m t\u0101 ir cikliska lieta, un tas bija ar\u012b viens no manas specialit\u0101tes izv\u0113les \u2013 ka es sapratu, ka t\u0101s vienm\u0113r b\u016bs aktu\u0101las. T\u0101 nu sakrita, ka tie\u0161i rezident\u016bras gaitas uzs\u0101kot, ar\u012b bija tas br\u012bdis, kad kovids bija tikko s\u0101cies, un \u0161\u012bs bailes un nezi\u0146a ar to kombin\u0113j\u0101s.<\/p>\n
Smags darbs gan fiziski, gan emocion\u0101li, jo es saprotu, ka t\u0101s bija cilv\u0113ku n\u0101ves vai ik dienu.<\/p>\n
Man tie bija ar\u012b t\u0101di jauni apst\u0101k\u013ci, jo tolaik ar\u012b mans pirmais rezident\u016bras rot\u0101cijas cikls bija Stradi\u0146a slimn\u012bcas pneimonolo\u0123ijas noda\u013c\u0101. Tas bija t\u0101ds gr\u016bts s\u0101kums, ar\u012b t\u0101p\u0113c, ka man vajadz\u0113ja adapt\u0113ties tie\u0161i slimn\u012bcas videi. Tie izaicin\u0101jumi bija gr\u016bti. T\u0101 bija nezi\u0146a un t\u0101s bija bailes s\u0101kum\u0101, bet, protams, \u0101rk\u0101rt\u012bgi svar\u012bgs bija kol\u0113\u0123u atbalsts.<\/p>\n
Bet k\u0101 visp\u0101r nelaist sev\u012b, teiksim, t\u0101das skumjas, ja tie\u0161\u0101m pacienti, kurus j\u016bs esat pal\u012bdz\u0113jusi \u0101rst\u0113t, nu, k\u0101 rezidents, ka, ka vi\u0146i aiziet?<\/p>\n
Tas ir \u013coti sare\u017e\u0123\u012bts jaut\u0101jums. Dro\u0161i vien katram t\u0101 atbilde ir cita. J\u0101m\u0113\u0123ina tas zelta vidusce\u013c\u0161 – balanss, un atbalsts ar\u012b no \u0123imenes un ar\u012b laiks ar sevi. Tas ir t\u0101ds milz\u012bgs darbs. Tas \u012bsti nemain\u0101s ar\u012b laika gait\u0101.<\/p>\n
Vai skol\u0101 augstskol\u0101 m\u0101c\u012bja, k\u0101 t\u0101d\u0101s situ\u0101cij\u0101s r\u012bkoties?<\/p>\n
Noteikti ir lietas, kam nevar sagatavoties. Dro\u0161i vien, ka t\u0101das pamatnost\u0101dnes tika iedotas, bet to nevar sal\u012bdzin\u0101t ar to br\u012bdi, kad tas notiek. T\u0101 doma, kas mierina \u0161\u0101d\u0101s situ\u0101cij\u0101s ir, ka tu esi dar\u012bjis visu, ko tu var\u0113ji izdar\u012bt taj\u0101 laik\u0101. Tas ir t\u0101ds vien\u012bgais, dro\u0161i vien, un tad jau noteikti tie faktori, kas vairs nav atkar\u012bgi no medic\u012bnas.<\/p>\n
Vai studenti ar\u012b bija pasarg\u0101ti? Tie\u0161i infektologs Pauls Aldi\u0146\u0161 bija tas, kur\u0161 \u013coti Stradi\u0146a slimn\u012bc\u0101 r\u016bp\u0113j\u0101s un run\u0101ja par to, ka vajag pasarg\u0101t, vakcin\u0113t pret kovidu ar\u012b studentus.<\/p>\n
J\u0101, j\u0101saka t\u0101, ka taj\u0101 laik\u0101 es biju slimn\u012bc\u0101, un es teiktu t\u0101, ka dro\u0161i vien t\u0101 ar\u012b bija katra kaut k\u0101d\u0101 m\u0113r\u0101 pa\u0161a izv\u0113le. Vai t\u0101 var\u0113tu teikt, ka bija pasarg\u0101ti – dro\u0161i vien, ka ne vair\u0101k, ne maz\u0101k k\u0101 visi p\u0101r\u0113jie.<\/p>\n
Vai j\u016bs sevi vair\u0101k identific\u0113jat k\u0101 p\u0113tnieci, zin\u0101tnieci vai dr\u012bz\u0101k k\u0101 kl\u012bnisko speci\u0101listu – dakteri, kas str\u0101d\u0101 tie\u0161i ar pacientiem?<\/p>\n
Dro\u0161i vien, atbilde ir kl\u012bniskais speci\u0101lists vair\u0101k. Ta\u010du taj\u0101 pat laik\u0101 \u0101rk\u0101rt\u012bgi svar\u012bgi ir \u0161ie jaut\u0101jumi no zin\u0101tnes puses. T\u0101pat es ar\u012b m\u0113\u0123in\u0101ju ar to domu vad\u012bties p\u0113tniecisk\u0101 darba izstr\u0101d\u0113. Uz t\u0101 balst\u0101s m\u016bsu zin\u0101tn\u0113 pie\u0146emtie l\u0113mumi. Un j\u0101saka, ka dro\u0161i vien kombin\u0101cija ir tas zelta variants. Ka ir gan t\u0101 kl\u012bnisk\u0101 puse, gan ar\u012b zin\u0101tnes puse<\/p>\n
Par t\u0101m \u0101rsta infektologa konsult\u0101cij\u0101m. Viens no galvenajiem jaut\u0101jumiem var\u0113tu b\u016bt antibiotiku rezistence?<\/p>\n
J\u0101, tas dro\u0161i vien ir ar\u012b tas galvenais aspekts, ar ko mans ikdienas darbs saist\u0101s. Ar\u012b vadl\u012bnij\u0101s, kas ir par antibiotiku lieto\u0161anu, m\u0113s redzam, ir t\u0101 emp\u012brisk\u0101 terapija. Tad, kad m\u0113s jau sa\u0146emam konkr\u0113tu uzs\u0113jumu datus – vai asins, vai kr\u0113pu vai ur\u012bna uzs\u0113jumi datus \u2013 m\u0113s redzam, kam k\u0101das antibiotikas b\u016btu vislab\u0101k\u0101s ar vis\u0161aur\u0101ko spektru, lai m\u0113s maz\u0101k selekcion\u0113tu antimikrobi\u0101lo rezistenci. Tas ir \u0161obr\u012bd \u0101rk\u0101rt\u012bgi b\u016btiski. Ar\u012b tas zi\u0146as paredzamo mirst\u012bbu no rezistentiem mikroorganismiem \u2013 ka 2050. gad\u0101 t\u0101 b\u016bs turpat, kur mirst\u012bba no v\u0113\u017ea. Tas tie\u0161\u0101m ir \u013coti b\u016btisks faktors, un m\u016bsu darbs ir \u2013 k\u0101 piem\u0113rot visefekt\u012bv\u0101ko terapiju, ko varam.<\/p>\n
Tas ar\u012b var\u0113tu b\u016bt infektolo\u0123ij\u0101 t\u0101ds liel\u0101kais izaicin\u0101jums tuv\u0101ko, piem\u0113ram, 25 gadu laik\u0101?<\/p>\n
Noteikti, tas noteikti ir viens no liel\u0101kajiem izaicin\u0101jumiem \u0161o gadu realit\u0101t\u0113, ne ilg\u0101 period\u0101.<\/p>\n
\nJa m\u0113s t\u0101 glob\u0101li skat\u0101mies par to, kad ir visp\u0101r biju\u0161as pieejamas antibiotikas, tad ir skaidrs, ka t\u0101 rezistence rodas \u0101tr\u0101k nek\u0101 jaunas un efekt\u012bvas antibiotikas.<\/p>\n<\/blockquote>\n
L\u012bdz ar to mums ir p\u0113c iesp\u0113jas j\u0101saudz\u0113 it \u012bpa\u0161i \u0161\u012bs pla\u0161a spektra antibiotikas, lai pacientiem visp\u0101r b\u016btu iesp\u0113jams terapija.<\/p>\n
\u0160aj\u0101 sarun\u0101 jau p\u0101ris reizes piemin\u0113tais Pauls Aldi\u0146\u0161, kura piemi\u0146as stipendiju sa\u0146\u0113m\u0101t, \u0101rpus darba vai nu m\u0101c\u012bj\u0101s arvien jaunas lietas \u2013 las\u012bja, vai ar\u012b mak\u0161\u0137er\u0113ja. Ko j\u016bs dar\u0101t br\u012bvaj\u0101 laik\u0101, lai tiktu prom no dom\u0101m par darbu?<\/p>\n
Pirmais \u2013 t\u0101da \u013coti b\u016btiska lieta, ko iesaka Pasaules Vesel\u012bbas organiz\u0101cija, ir staig\u0101\u0161ana. 30 min\u016btes tr\u012bs reizes ned\u0113\u013c\u0101 – tas b\u016btu absol\u016btais minimums. V\u0113l man pat\u012bk gleznot. Tas ir tas mans veids, kur es varu b\u016bt un rado\u0161i izpausties, un kas man pal\u012bdz atjaunoties.<\/p>\n","protected":false},"excerpt":{"rendered":"Infektolo\u0123ija ir pla\u0161a joma, kur katrs var ko sev atrast, \u0161\u012bs slim\u012bbas vienm\u0113r b\u016bs aktu\u0101las, un te diezgan…\n","protected":false},"author":2,"featured_media":91413,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[23,28,29,32,33,22,30,31,35,39,38,36,37,34,40,20,26,27,24,25,21],"class_list":{"0":"post-91412","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-latvija","8":"tag-aktualitates","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-featured-news","12":"tag-featurednews","13":"tag-headlines","14":"tag-latest-news","15":"tag-latestnews","16":"tag-latvia","17":"tag-latvian","18":"tag-latviesu","19":"tag-latviesu-valoda","20":"tag-latviesuvaloda","21":"tag-latvija","22":"tag-lv","23":"tag-news","24":"tag-popularakas-zinas","25":"tag-popularakaszinas","26":"tag-top-stories","27":"tag-topstories","28":"tag-zinas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115818521077683527","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/91412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=91412"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/91412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/91413"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=91412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=91412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=91412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}